November 19, 2020
FDA authorizes first home test for COVID-19
Editor's Note
The Food and Drug Administration (FDA) on November 17 issued an emergency use authorization for the first rapid COVID-19 self-test that a person can administer at home.
The Lucira COVID-19 All-In-One Test Kit has to be prescribed by a healthcare provider, and the healthcare provider has to report the results to public health authorities. The home test is for those 14 years of age or older.
The test also can be used in patient care settings, with nasal swab specimens collected by the provider in those under age 14.
Free Daily News
- Call for improved suicide risk screening in ASCs aims to strengthen safety protocols
- Study: Perioperative pregabalin reduces risk of kidney decline compared to gabapentin
- Medical school diversity declines after Supreme Court ruling
- Surgeons risk losing ground as transcatheter tricuspid valve interventions rise
- Bain Capital seeks full acquisition of Surgery Partners amid growing private equity interest in healthcare
- Study: Sleep surgery reduces motor vehicle accident risk in OSA patients
- Health systems embrace multi-year medical technology partnerships
- Health system leader survey respondents brace for 2025 shifts
- Initiative addresses nurses' underrepresentation in health media
- Pig organ transplant recipient remains healthy, sets xenotransplant record
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement